rs2274419
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005592.4(MUSK):c.1239G>A(p.Met413Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.128 in 1,613,518 control chromosomes in the GnomAD database, including 14,411 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M413T) has been classified as Uncertain significance.
Frequency
Consequence
NM_005592.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 9Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
- fetal akinesia deformation sequence 1Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MUSK | NM_005592.4 | c.1239G>A | p.Met413Ile | missense_variant | Exon 10 of 15 | ENST00000374448.9 | NP_005583.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MUSK | ENST00000374448.9 | c.1239G>A | p.Met413Ile | missense_variant | Exon 10 of 15 | 5 | NM_005592.4 | ENSP00000363571.4 | ||
| MUSK | ENST00000416899.7 | c.1239G>A | p.Met413Ile | missense_variant | Exon 10 of 14 | 5 | ENSP00000393608.3 | |||
| MUSK | ENST00000189978.10 | c.1005G>A | p.Met335Ile | missense_variant | Exon 10 of 14 | 5 | ENSP00000189978.6 | |||
| MUSK | ENST00000374438.1 | n.496G>A | non_coding_transcript_exon_variant | Exon 1 of 3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0988 AC: 15021AN: 151960Hom.: 964 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.120 AC: 29807AN: 249200 AF XY: 0.124 show subpopulations
GnomAD4 exome AF: 0.132 AC: 192302AN: 1461440Hom.: 13448 Cov.: 32 AF XY: 0.133 AC XY: 96646AN XY: 727022 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0988 AC: 15020AN: 152078Hom.: 963 Cov.: 32 AF XY: 0.100 AC XY: 7443AN XY: 74350 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:5
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
- -
- -
- -
- -
not provided Benign:1
- -
Fetal akinesia deformation sequence 1;C4225368:Congenital myasthenic syndrome 9 Benign:1
- -
Congenital myasthenic syndrome 9 Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at